JB THERAPEUTICS
JB Therapeutics is a clinical stage biopharmaceutical company developing the first new class of analgesic agents in two decades. Their lead compound, JBT-101, is a potent CB1 and CB2 agonist with demonstrated efficacy in several animal models of pain and inflammation. It has also completed a Phase II clinical study in chronic refractory neuropathic pain. JBT-101 is currently being developed as a potential disease modifying treatment for osteoarthritis. JBT-101 also represents a platform for combination with other anti-inflammatory and analgesic agents as well as various drug delivery strategies including ointment and gels, topical patches, and timed release formulations.
JB THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care Therapeutics
Founded:
2009-01-01
Address:
Newton Center, Massachusetts, United States
Country:
United States
Website Url:
http://www.jbtherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
1-617-413-3020
Email Addresses:
[email protected]
Total Funding:
687 K USD
Technology used in webpage:
Nginx Energy Group Hosting
Similar Organizations
AZTherapies
AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.
Certa Therapeutics
Certa Therapeutics is a clinical stage biotechnology company developing innovative therapies for the treatment of fibrotic diseases.
ImmunSYS
ImmunSYS is a clinical-stage biopharmaceutical company focused on the development of innovative cancer immunotherapy products.
JeniVision
JeniVision, are an innovative biopharmaceutical company that strives to discover advanced therapies for eye and skin diseases.
Mast Therapeutics
Mast Therapeutics is a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases.
Myosin Therapeutics
Myosin Therapeutics is a privately-held biopharmaceutical company developing novel medications for CNS-based disorders
Nivalis Therapeutics
Nivalis Therapeutics is a clinical-stage pharmaceutical company developing a novel class of disease modifying therapies.
Trophos
Trophos is a clinical stage pharmaceutical company developing innovative therapeutics for indications with under-served needs in neurology
TSG Therapeutics
TSG Therapeutics is a preclinical-stage biopharmaceutical firm dedicated to the abolition of viral infectious illness.
Viron, Inc.
Viron is a Next-Generation Anti-Viral Technology Company. Viron C1, its first product, a prophylactic against Covid is under FDA review.
Current Employees Featured
Founder
Investors List
Maine Angels
Maine Angels investment in Seed Round - JB Therapeutics
Maine Angels
Maine Angels investment in Venture Round - JB Therapeutics
Boston Harbor Angels
Boston Harbor Angels investment in Angel Round - JB Therapeutics
Official Site Inspections
http://www.jbtherapeutics.com
Unable to get host informations!!!
More informations about "JB Therapeutics"
上海药明巨诺生物科技有限公司
药明巨诺（港交所代码：2126）是一家独立的、创新型的生物科技公司，专注于研发、生产及商业化细胞免疫治疗产品，并致力于以创新为先导，成为细胞免疫治疗引领者。创建于2016年，药明巨诺已成功打造了国际领先的细胞免疫治疗的 …See details»
上海药明巨诺生物科技有限公司 - JW Therapeutics
JW Therapeutics (HKEX: 2126) is an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, and is committed to becoming an innovation leader …See details»
Overview - JW Therapeutics
JW Therapeutics (HKEX: 2126) is an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, and …See details»
JW Therapeutics 药明巨诺 - LinkedIn
JW Therapeutics is an innovative biotech company focusing on the latest clinical cell therapy technology. It is commited to the development, transformation and promotion of breakthrough …See details»
JW Therapeutics - Crunchbase Company Profile & Funding
JW Therapeutics is a developer of cell-based therapy technologies created to revolutionize cancer treatment.The company focuses on development, transformation and promotion of cell-based …See details»
JW Therapeutics Company Profile - Office Locations, Competitors …
JW Therapeutics has 5 employees across 4 locations and $90 m in total funding,. See insights on JW Therapeutics including office locations, competitors, revenue, financials, executives, …See details»
JW Therapeutics (Shanghai) Co., Ltd. - synapse.zhihuiya.com
了解JW Therapeutics (Shanghai) Co., Ltd. (上海药明巨诺生物科技有限公司)公司的药物管线，治疗领域，技术平台，以及它的8项临床试验, 655篇新闻和15篇文献，疾病领域:肿瘤，免疫系统 …See details»
JW Therapeutics (Suzhou) Co., Ltd. - synapse.zhihuiya.com
了解JW Therapeutics (Suzhou) Co., Ltd. (苏州药明巨诺生物科技有限公司)公司的药物管线，治疗领域，技术平台，以及它的4项临床试验, 1篇新闻，疾病领域:肿瘤，免疫系统疾病，血液及淋 …See details»
2seventy bio and JW Therapeutics Announce Intent To …
Sep 12, 2023 For more information, please visit www.jwtherapeutics.com. About 2seventy bio. Our name, 2seventy bio, reflects why we do what we do - TIME. Cancer rips time away, and our goal is to work at the ...See details»
JW Therapeutics Acquires Syracuse Biopharma and License to
Jul 20, 2020 Shanghai, China and Emeryville, California, July 20, 2020 – JW Therapeutics, a clinical stage biopharmaceutical company focused on developing, manufacturing and …See details»
JW Therapeutics Announces its Cell Immunotherapy …
Apr 25, 2022 As the first product of JW Therapeutics, Carteyva ® (relmacabtagene autoleucel injection) is a CAR-T product approved as a Category 1 biologics product. It was infused for treatment in the first ...See details»
JW Therapeutics Announces Two Appointments to Strengthen …
SHANGHAI, CHINA, January 10, 2022 - JW Therapeutics (HKEx: 2126), an independent, innovative biotechnology company focusing on developing, manufacturing and …See details»
2seventy bio and JW Therapeutics Announce Strategic Partnership …
Oct 27, 2022 For more information, please visit www.jwtherapeutics.com. About 2seventy bio Our name, 2seventy bio, reflects why we do what we do - TIME. Cancer rips time away, and …See details»
JW Therapeutics Announces Initiation of Clinical Study of …
SHANGHAI, March 8, 2023 /PRNewswire/ -- JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and …See details»
JW Therapeutics Announces its Cell Immunotherapy Drugs Have ...
SHANGHAI, CHINA, November 9, 2022 - JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and …See details»
JW Therapeutics Announces Exclusive Collaboration with 2seventy …
Jan 2, 2024 JW Therapeutics (HKEx: 2126), an independent innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy products, is …See details»
JW Therapeutics Announces its Cell Immunotherapy Drugs Have ...
SHANGHAI, Nov. 9, 2022 /PRNewswire/ -- JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and …See details»
JW Therapeutics Announces Receipt of Breakthrough Therapy …
Apr 3, 2022 /PRNewswire/ -- JW Therapeutics (HKEx: 2126), an independent, innovative biotechnology company focused on developing, manufacturing and commercializing cell...See details»
JW Therapeutics Announces IND Approval for the Clinical Trial of ...
SHANGHAI, Sept. 27, 2021 /PRNewswire/ -- JW Therapeutics (HKEx: 2126), an innovative biotechnology company focused on developing, manufacturing and commercializing cell …See details»
JW Therapeutics and 2seventy bio Announce Strategic Partnership …
For more information, please visit www.jwtherapeutics.com. About 2seventy bio. Our name, 2seventy bio, reflects why we do what we do - TIME. Cancer rips time away, and our goal is to …See details»